Placenta previa is defined as the placenta partially or completely overlying the internal cervical os, with low-lying placenta referring to a placental edge within 2 cm of the os but not covering it. [1-2] Prevalence is 1–4% at mid-trimester scan but resolves in most cases, persisting in only 0.3–0.5% at term. [1][3] It is a leading cause of antepartum hemorrhage and an absolute indication for cesarean delivery when persistent. [3]
The following management algorithm summarizes the key decision points based on bleeding status and gestational age:
1. History
- Classic presentation: Painless, bright red vaginal bleeding in the late second or third trimester — often described as "sentinel bleed" [1]
- Timing: onset, duration, volume (number of pads soaked), intermittent vs. continuous
- Precipitating events: intercourse, Valsalva maneuver, physical activity (though most episodes have no identifiable trigger) [1]
- Presence or absence of contractions, abdominal pain, leaking fluid
- Prior ultrasound results — was placental location documented at anatomy scan?
- Obstetric history: prior cesarean deliveries (number), prior uterine surgery, prior previa
- Current pregnancy: gestational age, ART conception, multiple gestation
2. Alarm Features
- Massive hemorrhage with hemodynamic instability (tachycardia, hypotension)
- Nonreassuring fetal heart rate tracing
- Coagulopathy or signs of DIC
- Concurrent contractions suggesting preterm labor with previa
- Suspected placenta accreta spectrum (especially with prior cesarean + anterior previa) — risk of catastrophic hemorrhage at delivery [1][3]
- Concurrent vasa previa (fetal vessels over the os) — high perinatal mortality if undiagnosed [2]
3. Medications
- Antenatal corticosteroids: Betamethasone 12 mg IM × 2 doses 24 hours apart if <37 weeks and delivery anticipated within 7 days [4]
- Tocolytics: May be considered short-term to allow steroid administration; no strong evidence for routine use
- Anti-D immunoglobulin: Administer to all unsensitized Rh-negative patients with bleeding [5]
- Iron supplementation for chronic blood loss/anemia
- Contraindicated: Digital cervical examination is absolutely contraindicated [1]
- Avoid anticoagulants when possible; if on therapeutic anticoagulation, multidisciplinary planning is essential
4. Diet
- No specific dietary triggers or restrictions unique to placenta previa
- Ensure adequate iron-rich diet to support hematopoiesis given recurrent bleeding risk
- Maintain hydration, especially during hospitalization or activity restriction
5. Review of Systems
- OB: vaginal bleeding (quantity, color), contractions, fetal movement, leaking fluid, vaginal discharge
- GI: abdominal pain (distinguish from abruption), nausea
- GU: urinary symptoms (rule out UTI as bleeding source)
- Heme: lightheadedness, syncope, fatigue (anemia symptoms)
- Psych: anxiety, depression — psychological burden is significant, especially in complicated cases [3]
6. Collateral History and Family History
- Confirm gestational age and prior imaging results from prenatal records
- Prior obstetric history from partner/family if patient unable to provide
- Family history is generally not a major contributor, though prior personal history of previa carries a 4–8% recurrence risk [3]
- Social context: distance from hospital, home support, transportation access — these influence inpatient vs. outpatient management decisions [4]
7. Risk Factors
8. Differential Diagnosis
- Placental abruption: Typically painful bleeding with uterine tenderness/rigidity; may have concealed hemorrhage; associated with hypertension and trauma [1]
- Vasa previa: Fetal vessels over the os; bleeding is fetal blood (Apt test positive for fetal hemoglobin); high fetal mortality [1-2]
- Cervical pathology: Cervicitis, cervical polyps, cervical ectropion, cervical cancer — identified on speculum exam [1]
- Bloody show / labor: Mucus-tinged blood with contractions and cervical change
- Uterine rupture: Prior uterine scar, acute pain, fetal distress
- Lower genital tract trauma or infection
- Marginal sinus rupture
9. Past Medical History
- Number and type of prior deliveries (vaginal vs. cesarean)
- Prior uterine surgeries (myomectomy, D&C, hysteroscopy)
- Prior episodes of antepartum hemorrhage in this or prior pregnancies
- History of infertility treatment
- Chronic conditions: hypertension, diabetes, coagulopathies
- Prior uterine artery embolization — a novel risk factor for antepartum hemorrhage in previa [10]
10. Physical Exam
- Vital signs: Tachycardia and hypotension suggest significant hemorrhage; assess for orthostatic changes
- Abdominal exam: Soft, nontender uterus (in contrast to abruption); assess fundal height, fetal lie/presentation (malpresentation is common with previa)
- Sterile speculum exam: Safe to perform — assess volume and source of bleeding, rule out cervical/vaginal pathology [1]
- ⚠ Digital cervical exam is CONTRAINDICATED until previa is excluded [1]
- Fetal monitoring: Continuous electronic fetal monitoring to assess fetal status
- Transvaginal ultrasound is safe and should be performed — the probe is placed in the anterior vaginal fornix, not the cervix [1]
11. Lab Studies
12. Imaging
- First-line: Transabdominal ultrasound — assess placental location, inferior margin, relationship to internal os [11]
- Gold standard: Transvaginal ultrasound — confirms transabdominal findings, precisely measures placental edge-to-os distance, and evaluates for vasa previa and placenta accreta spectrum [3][11]
- Safe in the setting of known or suspected previa [2][11]
- Use color and pulsed Doppler to rule out vasa previa [2]
- MRI: Reserved for suspected placenta accreta spectrum when ultrasound is inconclusive, particularly with posterior placenta [1]
- Follow-up imaging schedule (asymptomatic):
- If previa or low-lying at mid-trimester → repeat at 32 weeks [2][12]
- If persistent at 32 weeks → repeat transvaginal US at 36 weeks [2][12]
- Earlier imaging if symptomatic [2]
13. Special Tests
- Apt test: Differentiates fetal from maternal blood — critical if vasa previa is suspected
- Kleihauer-Betke test: Quantifies fetomaternal hemorrhage for Rh immunoglobulin dosing
- Fetal lung maturity testing: Historically used via amniocentesis at 36 weeks; largely replaced by gestational age-based delivery timing [13]
- Cervical length measurement: Short cervical length (<2.5 cm) and preterm contractions are significant risk factors for antepartum hemorrhage in previa; however, SMFM does not recommend routine cervical length screening in previa due to lack of management data (GRADE 2C) [10][14-15]
14. ECG
- Not routinely indicated for placenta previa
- Consider ECG if hemodynamically unstable, significant hemorrhage, or tachycardia to rule out cardiac contribution
- Pregnancy-related ECG changes (sinus tachycardia, axis deviation, nonspecific ST changes) should be interpreted in clinical context
15. Assessment
Classification (current terminology per SMFM/ACOG): [2]
- Placenta previa: Placental edge covers the internal cervical os
- Low-lying placenta: Placental edge within 2 cm of the os but not covering it
- Terms "partial" and "marginal" have been eliminated from the recommended classification
Severity stratification
- Asymptomatic (incidental finding on ultrasound) — most common presentation today [7]
- Symptomatic with self-limited bleeding — ~50% of patients present this way [1]
- Symptomatic with hemodynamic instability — obstetric emergency
Key complications to anticipate
- Antepartum hemorrhage (40–60%), postpartum hemorrhage (20–35%) [3]
- Preterm delivery (>40% deliver before 37 weeks) [3]
- Placenta accreta spectrum (especially with prior cesarean + previa) [1][4]
- Hysterectomy, ICU admission, fetal growth restriction [1]
16. Treatment Plan
Initial stabilization (ED/L&D)
- ABCs, two large-bore IVs, crystalloid resuscitation
- Type and crossmatch, activate massive transfusion protocol if needed
- Continuous fetal monitoring
- Sterile speculum exam (NO digital exam)
- Urgent OB consultation
Antenatal management
- Asymptomatic previa: Outpatient monitoring with pelvic rest (though evidence for pelvic rest is limited); avoid intercourse, heavy lifting [1][16]
- Bleeding episode: Hospitalize for stabilization and monitoring; if bleeding resolves and maternal/fetal status stable, may discharge with close outpatient follow-up [1][13]
- Antenatal corticosteroids: Betamethasone if 23⁰–36⁶ weeks and delivery anticipated [4]
- Anti-D immunoglobulin for Rh-negative patients [5]
Delivery timing
- Uncomplicated previa: Planned cesarean at 36⁰–37⁶ weeks (SMFM GRADE 1B) [1][3][15]
- Previa with suspected accreta: Planned delivery at 34 weeks with multidisciplinary team [4]
- Low-lying placenta (edge 11–20 mm from os): Trial of labor may be considered [3]
- Placental edge ≥10 mm from os: Vaginal delivery is reasonable, though higher risk of emergency cesarean [1]
- Emergency cesarean: Indicated for severe hemorrhage, hemodynamic instability, or nonreassuring fetal heart rate regardless of gestational age [1]
Operative preparedness
- Multidisciplinary "placenta team" (OB, anesthesia, ± interventional radiology, ± urology) [3]
- Blood products immediately available
- Consider cell salvage
17. Disposition
Outpatient management of symptomatic previa (after stabilization) has been shown to be a safe alternative to prolonged inpatient management in selected patients, with significant cost savings. [13]
18. Follow Up / Return Precautions
- Follow-up imaging: Repeat transvaginal ultrasound at 32 weeks and again at 36 weeks if previa persists [2][12]
- Return immediately for: Any vaginal bleeding, regular contractions, decreased fetal movement, leaking fluid, lightheadedness/syncope
- Counseling points:
- Avoid intercourse, douching, and tampons (pelvic rest) [1][4]
- Activity restriction should be individualized — routine bed rest is not evidence-based [1]
- Keep hospital bag packed; have a plan for rapid transport
- Most second-trimester previas resolve by term (~50% of previas resolve; ~75% of low-lying placentas resolve by 28 weeks) [16]
- Expected course: If previa persists, planned cesarean at 36–37⁶ weeks; if it resolves (edge ≥2 cm from os), routine obstetric care with vaginal delivery [1]
- Postpartum: Structured debriefing and psychological support recommended, especially after complicated cases [3]
References
1. Late Pregnancy Bleeding. — Yonke N, Gurule FS, Rosenfeld-O'Tool S. American Family Physician. 2025.
2. Fetal Imaging: Executive Summary of a Joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, American Institute of Ultrasound in Medicine, American College of Obstetricians and Gynecologists, American College of Radiology, Society for Pediatric Radiology, and Society of Radiologists in Ultrasound Fetal Imaging Workshop. — Reddy UM, Abuhamad AZ, Levine D, Saade GR, Fetal Imaging Workshop Invited Participants*. Obstetrics and Gynecology. 2014.
3. Cesarean Delivery for Placenta Previa. — Cassardo O, Orsi M, Ossola MW, Perugino G, Cetin I. American Journal of Obstetrics and Gynecology. 2026.
4. Placenta Accreta Spectrum. — Silver RM, Branch DW. The New England Journal of Medicine. 2018.
5. Interventions for Suspected Placenta Praevia. — Neilson JP. The Cochrane Database of Systematic Reviews. 2000.
6. Evaluation of Risk Factors and Pregnancy Outcome of Placenta Previa in a Long-Term Comparative Single-Center Study. — Brandstetter M, Eiben C, Bogner G, et al. The Journal of Maternal-Fetal & Neonatal Medicine : The Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2025.
7. Placenta Previa. — Oyelese Y, Shainker SA. Clinical Obstetrics and Gynecology. 2025.
8. Risk Factors for Antepartum Haemorrhage in Women With Placenta Praevia. — Treffers A, Reynoldson O, Beckmann M. The Australian & New Zealand Journal of Obstetrics & Gynaecology. 2025.
9. Blood Type and Outcomes in Pregnant Women with Placenta Previa. — Fan D, Rao J, Zhang H, et al. Oxidative Medicine and Cellular Longevity. 2022.
10. Maternal and Neonatal Outcomes Resulting From Antepartum Hemorrhage in Women With Placenta Previa and Its Associated Risk Factors: A Single-Center Retrospective Study. — Long SY, Yang Q, Chi R, et al. Therapeutics and Clinical Risk Management. 2021.
11. ACR Appropriateness Criteria® Second and Third Trimester Vaginal Bleeding. — Expert Panel on GYN and OB Imaging, Shipp TD, Poder L, et al. Journal of the American College of Radiology : JACR. 2020.
12. AIUM Practice Parameter for the Performance of Limited Obstetric Ultrasound Examinations by Advanced Clinical Providers. — Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine. 2018.
13. Management of the Symptomatic Placenta Previa: A Randomized, Controlled Trial of Inpatient Versus Outpatient Expectant Management. — Wing DA, Paul RH, Millar LK. American Journal of Obstetrics and Gynecology. 1996.
14. Risk Factors and Pregnancy Outcomes of Antepartum Hemorrhage in Women With Placenta Previa. — Im DH, Kim YN, Cho EH, et al. Reproductive Sciences. 2023.
15. Society for Maternal-Fetal Medicine (SMFM) Consult Series #44: Management of Bleeding In the Late Preterm Period. — Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.org, Gyamfi-Bannerman C. American Journal of Obstetrics and Gynecology. 2018.
16. Impact of Pelvic Rest Recommendations on Follow-Up and Resolution of Placenta Previa and Low-Lying Placenta. — Greenwood L, Mastrobattista J, Mack L, et al. Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine. 2023.